Literature DB >> 15153940

Mice overexpressing human caspase 3 appear phenotypically normal but exhibit increased apoptosis and larger lesion volumes in response to transient focal cerebral ischaemia.

L E Kerr1, A L McGregor, L E A Amet, T Asada, C Spratt, T E Allsopp, A J Harmar, S Shen, G Carlson, N Logan, J S Kelly, J Sharkey.   

Abstract

Caspase 3 activation has been implicated in cell death following a number of neurodegenerative insults. To determine whether caspase genes can affect the susceptibility of cells to neurodegeneration, a transgenic mouse line was created, expressing human caspase 3 under control of its own promoter. The human gene was regulated by the murine homeostatic machinery and human procaspase 3 was expressed in the same tissues as mouse caspase 3. These novel transgenic mice appeared phenotypically and developmentally normal and survived in excess of 2 years. Behavioural assessment using the 5-choice serial reaction time task found no differences from wild-type littermates. Caspase activity was found to be tightly regulated under physiological conditions, however, significantly larger lesions were obtained when transgenic mice were subjected to focal cerebral ischaemia/reperfusion injury compared to wild-type littermates. These data demonstrate that mice overexpressing human caspase 3 are essentially normal, however, they have increased susceptibility to degenerative insults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153940     DOI: 10.1038/sj.cdd.4401449

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  9 in total

Review 1.  The role of glutamate in neuronal ischemic injury: the role of spark in fire.

Authors:  Botros B Kostandy
Journal:  Neurol Sci       Date:  2011-11-02       Impact factor: 3.307

2.  Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

Authors:  Guanghong Liao; Miou Zhou; Simon Cheung; James Galeano; Nam Nguyen; Michel Baudry; Xiaoning Bi
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

3.  Establishment of the expression system for studying the function of active caspase-3 in zebrafish.

Authors:  Ho-Young Kim; Goo-Young Kim; Sang-Soo Kim; Min-Kyung Nam; Hyangshuk Rhim
Journal:  Mol Biol Rep       Date:  2007-12-13       Impact factor: 2.316

Review 4.  Measuring impulsivity in mice: the five-choice serial reaction time task.

Authors:  Sandra Sanchez-Roige; Yolanda Peña-Oliver; David N Stephens
Journal:  Psychopharmacology (Berl)       Date:  2011-11-18       Impact factor: 4.530

5.  Evaluation of schistosome promoter expression for transgenesis and genetic analysis.

Authors:  Shuang Liang; Melissa Varrecchia; Kenji Ishida; Emmitt R Jolly
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

6.  Protective effect of angiotensin-(1-7) against hyperglycaemia-induced injury in H9c2 cardiomyoblast cells via the PI3K̸Akt signaling pathway.

Authors:  Yi-Ying Yang; Xiu-Ting Sun; Zheng-Xun Li; Wei-Yan Chen; Xiang Wang; Mei-Ling Liang; Hui Shi; Zhi-Sheng Yang; Wu-Tao Zeng
Journal:  Int J Mol Med       Date:  2017-12-15       Impact factor: 4.101

7.  Association Between a Polymorphism in CASP3 and CASP9 Genes and Ischemic Stroke.

Authors:  Bae Youl Lee; Jinmann Chon; Hee-Sang Kim; Jong Ha Lee; Dong Hwan Yun; Seung Don Yoo; Dong Hwan Kim; Seung Ah Lee; Yoo Jin Han; Hyunseok Lee; Jin Chul Kim; Yunsoo Soh; Joo-Ho Chung; Su Kang Kim; Hae Jeong Park
Journal:  Ann Rehabil Med       Date:  2017-04-27

8.  Differential gene expression profiles between two subtypes of ischemic stroke with blood stasis syndromes.

Authors:  Tian-Long Liu; Min-Na Liu; Xin-Liang Xu; Wen-Xing Liu; Pei-Jin Shang; Xiao-Hu Zhai; Hang Xu; Yi Ding; Yu-Wen Li; Ai-Dong Wen
Journal:  Oncotarget       Date:  2017-12-04

9.  The role of the purinergic P2X7 receptor in inflammation.

Authors:  Martin F Lister; John Sharkey; Deborah A Sawatzky; Joseph P Hodgkiss; Donald J Davidson; Adriano G Rossi; Keith Finlayson
Journal:  J Inflamm (Lond)       Date:  2007-03-16       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.